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Abstract
Introduction The local production of pathogenic autoantibodies
by plasma cells in synovium is one of the hallmarks of
rheumatoid arthritis (RA). There may be a potential link between
ectopic lymphoid neogenesis and the local autoimmunity in
rheumatoid synovium. The unfolded protein response (UPR) has
key roles in the development and maintenance of plasma cells
secreting immunoglobulin. This study was designed to explore
the potential links between the activation of the UPR of
infiltrating plasma cells in inflamed peripheral joints and the
histopathological variants of rheumatoid synovitis as well as the
local production of pathogenic autoantibodies.
Methods The variants of rheumatoid synovium were
histopathologically classified into follicular and diffuse synovitis.
Immunohistochemical and double-immunofluorescent stainings
were performed to detect the expression of 78-kDa glucose-
regulated protein (GRP78), a marker of activation of the UPR, in
infiltrating plasma cells of synovium, and flow cytometry and
immunoblotting analyses were performed to quantify GRP78 in
plasma cells of synovial fluid in inflamed peripheral joints of RA.
The detections were also taken in osteoarthritis (OA) as
controls. The synovial fluid levels of anti-cyclic citrullinated
peptide antibodies (anti-CCP) (IgG) were quantified with the
enzyme-linked immunosorbent assay and corrected to those of
total IgG in RA.
Results Expressions of GRP78 were more intensive in
infiltrating plasma cells in RA synovium relative to those in OA
synovium (P < 0.001) and in synovium with follicular synovitis
relative to that with diffuse synovitis (P < 0.001). Analyses by
flow cytometry and immunoblotting showed that there was a
significant upregulation of GRP78 of plasma cells from synovial
fluid of RA compared with that of OA (P  < 0.05) and from
synovial fluid of follicular synovitis relative to that of diffuse
synovitis (P < 0.05). Moreover, a positive relationship between
the expression of GRP78 of plasma cells from synovial fluid and
the corrected synovial levels of anti-CCP (IgG) was seen in RA
(P < 0.001).
Conclusions There may be a link between enhanced activation
of the UPR of plasma cells and ectopic lymphoid neogenesis as
well as the local production of anti-CCP (IgG) in inflamed
peripheral joints of RA.
Introduction
Rheumatoid arthritis (RA) is a systemic inflammation disease
characterized by chronic and invasive synovitis that causes
cartilage destruction and subchondral bone erosion [1]. The
infiltrating plasma cells in rheumatoid synovium could synthe-
size the pathogenic autoantibodies such as anti-cyclic citrulli-
nated peptide antibodies (anti-CCP) [2], which can be of both
diagnostic and prognostic value for early-onset or established
RA [3,4]. In addition, it has previously been documented that
there may be a potential link between ectopic lymphoid neo-
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genesis, which is characterized by the formation of lymphoid
follicle with germinal center response and can facilitate the ter-
minal differentiation of B cells into plasma cells in rheumatoid
synovium [5], and the local production of high-affinity patho-
genic autoantibodies [6,7].
In rheumatoid synovium, the terminal differentiation of B cells
into plasma cells in response to antigenic stimuli could require
a massive increase in the biosynthetic capacity to produce the
autoantibodies within the endoplasmic reticulum (ER) [8-10].
The ER stress response or activation of the unfolded protein
response (UPR) can ensue. The UPR can play key roles in the
development and maintenance of the plasma cells secreting
immunoglobulin [8,9] and may be essential to allow plasma
cells to become secretary factories dedicated to high-level
autoantibody production [11,12].
Activation of the UPR in plasma cells can promote the expres-
sion of ER chaperones, such as 78-kDa glucose-regulated
protein (GRP78), mainly via ER transmembrane protein Ire1
(inositol-requiring kinase 1) and ATF6 (activating transcription
factor 6) signaling pathways [10,11,13]. GRP78, which is also
referred to as immunoglobulin heavy-chain-binding protein
(BiP), is a molecular chaperone that binds transiently to pro-
teins traversing through the ER and facilitates their folding,
assembly, and transport. As the master regulator of the ER,
GRP78 represents an important prosurvival component of the
secretary cells, including antibody-secreting plasma cells [14-
16]. Moreover, the induction of GRP78 can be used for the
quantitative measurement of events in activation of the UPR
[16].
Previous studies have indicated that GRP78/BiP is overpro-
duced in inflamed synovium [17] and may have immunogenic
roles in driving the local and systemic autoimmunity in RA
[18,19]. In addition, GRP78/BiP has been reported to exert
regulatory activities for inflammation and to prevent the inflam-
matory lesions in experimental arthritis [18]. Nevertheless,
there were few reports on the expression of GRP78/BiP or its
potential link with the histopathological variants of rheumatoid
synovitis and the local production of autoantibodies or on the
induction of the UPR in infiltrating plasma cells within rheuma-
toid peripheral joints. In the present work, we investigated the
expression of GRP78 of plasma cells in both synovial tissue
and fluid in inflamed peripheral joints of RA, trying to explore
the expressional profiles of GRP78 of plasma cells in distinct
histological variants of rheumatoid synovitis and thus to deter-
mine whether there was a potential link between activation of
the UPR of plasma cells and ectopic lymphoid neogenesis in
rheumatoid synovium as well as the local production of patho-
genic autoantibody such as anti-CCP.
Materials and methods
Patients and samples
Synovium and synovial fluid were taken at total knee arthro-
plasty or arthroscopic synovectomy for the inflammatory
peripheral joints in Xijing Hospital from 24 RA patients (7
males and 17 females). All of the RA patients fulfilled the 1987
revised diagnostic criteria of the American College of Rheu-
matology [20]. The mean age of the patients was 40.6 ± 11.9
years, and the median disease duration was 3.0 years. The
mean erythrocyte sedimentation rate was 47.1 ± 20.4 mm/
hour, and the mean serum level of C-reactive protein was 3.85
± 2.04 mg/dL. Among all of the 24 RA patients, 18 were sero-
positive and 6 were seronegative for anti-CCP (IgG) (cutoff
value of 5 RU/mL). Synovium tissues from 12 osteoarthritis
(OA) patients and synovial fluid from 10 of 12 OA patients
were also obtained under diagnostic arthroscopy as controls.
Ethics approval for this study was granted from the medical
ethics committee of Xijing Hospital, and all of the subjects
gave their informed consent.
Histopathological evaluations
Synovial tissue samples underwent routine staining with
hematoxylin and eosin (HE). The variants of rheumatoid syno-
vitis were analyzed under light microscopy (BX60; Olympus,
Tokyo, Japan) and determined mainly as previously described
[6,21], with particular attention to cell infiltrating density, the
topographical arrangement of lymphocytes and macrophages,
the distribution of high endothelial venules, and the relation-
ship of lymphocytes to the adjacent vasculars. The variants of
rheumatoid synovitis in this study were subsequently catego-
rized into follicular synovitis characterized by the formation of
discrete lymphoid follicles, part of which presented the germi-
nal center reaction with apparent central clearing of the lym-
phoid aggregates, and into diffuse synovitis characterized by
diffuse lymphocyte infiltrations in the sublining layers of rheu-
matoid synovium without further microanatomical organization.
Immunohistochemical staining
The streptavidin/peroxidase (SP) immunohistochemical stain-
ings were performed in synovium from all of the 24 RA and 12
OA patients. Briefly, serial synovium sections (4 to 5 μm thick)
embedded in paraffin were dewaxed and hydrated. The sec-
tions were placed in 3% H2O2 in methanol to block endog-
enous peroxidase, incubated with 10% normal rabbit
nonimmune serum for 10 minutes to minimize background
staining, and incubated with 1:100 anti-GRP78 goat polyclo-
nal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA) for 60 minutes at room temperature. Normal goat serum
IgG (Santa Cruz Biotechnology, Inc.) was used as a control for
the primary antibody. After a wash with phosphate-buffered
saline (PBS) (pH 7.2 to 7.4), the sections were incubated with
biotinylated rabbit anti-goat secondary antibody (Zymed Labo-
ratories, Inc., now part of Invitrogen Corporation, Carlsbad,
CA, USA) for 10 minutes at room temperature. The sections
were then incubated with peroxidase-conjugated streptavidinAvailable online http://arthritis-research.com/content/11/1/R4
Page 3 of 9
(page number not for citation purposes)
(Invitrogen Corporation) for 10 minutes. After a wash with
PBS, substrate reagents (diaminobenzidine) were added.
Finally, the counterstaining was performed with hematoxylin
and the sections were mounted.
To facilitate statistical analysis, GRP78 immunoperoxidase
staining for infiltrating plasma cells of two representative sec-
tions per patient was scored by three researchers (XL, YF, and
CF), and the mean values were reported as follows: 1 = no or
weak staining, 2 = moderate staining, 3 = strong staining, and
4 = very strong staining. Researchers were not informed of the
data of the patients. When the GRP78 staining of infiltrating
plasma cells of synovium from the patients was not scored
consistently, discussions were performed until agreements
were reached among the three researchers.
Double-immunofluorescent staining
Fresh synovial tissue specimens from all of the RA and OA
patients were snap-frozen immediately, and serial cryostat
sections (6 μm thick) were prepared. After being fixed with 4%
paraformaldehyde, the sections were treated with 10% normal
rabbit nonimmune serum for 30 minutes and then incubated
with 1:100 anti-CD138 mouse monoclonal antibody (Serotec,
Oxford, UK) and 1:100 anti-GRP78 goat polyclonal antibody
(Santa Cruz Biotechnology, Inc.) overnight at 4°C. The normal
mouse and goat IgGs (Santa Cruz Biotechnology, Inc.) were
used to replace the primary antibodies as negative controls.
After a wash in PBS (pH 7.2 to 7.4), the sections were incu-
bated with 1:100 cyanine-3-labeled sheep anti-mouse IgG
(Sigma-Aldrich, St. Louis, MO, USA) and 1:100 fluorescein
isothiocyanate (FITC)-labeled rabbit anti-goat IgG (Sigma-
Aldrich) in PBS (containing 1% bovine serum albumin [BSA],
pH 7.2 to 7.4) in the dark for 1 hour. Finally, the sections were
washed with PBS and mounted with glycerol. The sections
were then analyzed and photographed with a confocal laser
scanning microscope (FV 1000; Olympus).
Flow cytometry analysis
Mononuclear cells from heparinized synovial fluid of 24 RA
and 10 OA patients were incubated with hyalidase (Sigma-
Aldrich) at 37°C for 30 minutes before being isolated with the
Ficoll-Hypaque (Sigma-Aldrich) gradient centrifugation
method. Separated synovial fluid cells (106/mL) were incu-
bated with phycoerythrin-conjugated anti-CD138 mouse mon-
oclonal antibody (BD Biosciences, San Jose, CA, USA) and
FITC-conjugated anti-GRP78 goat polyclonal antibody (Santa
Cruz Biotechnology, Inc.). The FITC-conjugated goat IgG
(SouthernBiotech, Birmingham, AL, USA) was used as a con-
trol. Before being incubated with FITC-conjugated anti-
GRP78 goat polyclonal antibody, the synovial cells were
treated with fluorescence-activated cell sorting (FACS) per-
meabilizing solution (BD Biosciences). CD138+ cells were
gated on lymphocytes of synovial fluids, and 5,000 events
were measured. Cells were analyzed with FACS Calibur flow
cytometry (BD Biosciences). Data were processed using Cell
Quest software (BD Biosciences).
Plasma cell isolation and Western blotting
Mononuclear cells isolated from synovial fluid of the 24 RA
and 10 OA patients, as mentioned above, were sorted by
CD138 microbeads (Miltenyi Biotec, Auburn, CA, USA) in
accordance with the manufacturer's instructions. Briefly,
mononuclear cells were incubated at a concentration of 1 ×
108 cells per milliliter with CD138 microbeads at a titre of 1:5
for 30 minutes at 4°C. Then the cells were washed once with
PBS buffer containing 5 mM EDTA (ethylenediaminetetraace-
tic acid) and 0.5% BSA (PBS/EDTA/BSA). After being resus-
pending in 2 mL of PBS/EDTA/BSA, cells were separated
using two sequential MS columns (Miltenyi Biotec). After esti-
mation of the percentage of plasma cells expressing CD138
by FACS analysis (>95%), the isolated cells were lysed at 4°C
for 1 hour in the lysis buffer, consisting of 20 mM Tris (pH 7.8),
100 mM NaCl, 10 mM EDTA, 1% Triton X-100, 5 mM iodoa-
cetamide, 5 μg/mL aprotinin, 10 μg/mL leupeptin, 10 μg/mL
pepstatin A, 0.04% sodium azide, and 1 mM phenylmethyl-
sulphonyl fluoride. Nuclei and cell debris were then pelleted at
10,000 g for 5 minutes at 4°C, and the supernatants were
used for Western blotting.
Supernatant protein concentrations were firstly assessed with
a bicinchoninic acid protein assay reagent kit (Pierce Biotech-
nology, now part of Thermo Fisher Scientific Inc., Rockford, IL,
USA) in accordance with the manufacturer's protocols, and
the plasma cell extracts were finally adjusted to 30 μg of total
protein per sample in Laemmli buffer. Then the supernatants
were electrophoresed in SDS-PAGE according to the method
of Laemmli [22]. After electrophoresis, the gels were blotted
onto nitrocellulose filter membranes (Bio-Rad Laboratories,
Hercules, CA, USA). After blocking with 4% defatted milk
powder in TBST (1 mL of Tween 20 in 1 L of Tris-buffered
saline) at room temperature for 1.5 hours, the membranes
were incubated with a 1:1,000 dilution of anti-GRP78 rabbit
polyclonal antibody (Santa Cruz Biotechnology, Inc.) or 1:500
anti-actin rabbit antibody (Sigma-Aldrich) for 1 hour. Anti-
GRP78 rabbit polyclonal antibodies were omitted as conju-
gate controls. The membranes were then incubated with
1:3,000 horseradish peroxidase-labeled goat anti-rabbit IgG
(Santa Cruz Biotechnology, Inc.) at room temperature for 1
hour. Between the above steps, the membranes were washed
with TBST for 5 minutes × 3. Finally, the immunolabeled bands
were visualized by chemiluminescence with an enhanced
chemiluminescence Western blot detection kit (Amersham
Biosciences, now part of GE Healthcare, Little Chalfont, Buck-
inghamshire, UK), exposed to film, and quantified with the
GeneGnome and GeneTools image scanning and analysis
package (Syngene Ltd., a division of the Synoptics Group,
Cambridge, UK). Prestained standards of low-range molecular
weight were used to determine protein size (Sigma-Aldrich).
The raw values of densitometric analyses were used to identifyArthritis Research & Therapy    Vol 11 No 1    Dong et al.
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the expressional intensities of GRP78 and actin. The relative
levels of expression of GRP78 of plasma cells were deter-
mined by the expressional intensities being normalized to
actin.
Synovial fluid levels of anti-CCP
Detection of anti-CCP (IgG) of the synovial fluids of RA joints
was performed with an enzyme-linked immunosorbent assay
kit (Euroimmun, Lübeck, Germany) in accordance with the
manufacturer's protocols. Patient samples were diluted 1:101
in sample buffer. According to the standard curve made from
the five calibration sera, the synovial fluid levels of anti-CCP
(RU/mL) were quantified. If the extinction value of a patient
sample lay above that of calibrator 5 (200 RU/mL), the sample
was measured in a new test run at a dilution of 1:400 and the
result in relative units per milliliter read from the standard curve
for this sample was then multiplied by a factor of 4. Finally, the
corrected synovial fluid levels of anti-CCP were determined by
being normalized to those of total IgG (g/L), which were deter-
mined by the reagents kit of the Immage Immunochemistry
System (Beckman Coulter, Inc., Fullerton, CA, USA).
Statistics
Data are expressed as mean ± standard deviation. Statistical
analysis was performed with the Mann-Whitney U  test in
SPSS 12.0 for Windows (SPSS Inc., Chicago, IL, USA) for
comparison of the means and with the Spearman's rho for the
correlation tests. P values of less than 0.05 were considered
statistically significant.
Results
Histopathological patterns of rheumatoid synovium
Synovia from 13 RA patients analyzed by HE staining showing
that there were diffuse lymphocyte infiltrations without further
microanatomical organization were classified as diffuse syno-
vitis in this study. In synovia sampled from the other 11 RA
patients, lymphoid aggregates were extensive and assumed
the appearance of discrete lymphoid follicles, part of which
presented the formation of germinal center, and the synovia
were categorized as follicular synovitis. Nine of 11 of RA
patients with follicular synovitis and 9 of 13 of those with dif-
fuse synovitis were seropositive for anti-CCP. Fibrinoid necro-
biotic granulomas were found in synovia from only 2 RA
patients with follicular synovitis. Figure 1a–c shows the typical
synovia from patients with the variants of rheumatoid synovitis.
The expression of GRP78 of infiltrating plasma cells in 
rheumatoid synovium
The infiltrating plasma cells in both RA and OA synovia could
be clearly identified by their eccentrically positioned nuclei sur-
rounded by abundant cytoplasm and often a perinuclear halo.
The SP immunohistochemical stainings showed the clear and
intensive stainings of GRP78 in infiltrating plasma cells in RA
synovium, especially in those with follicular synovitis, in con-
trast to no or only weak stainings in infiltrating plasma cells in
OA synovium (Figure 1d–l). The double-immunofluorescent
staining showed the localization of GRP78 in membrane sur-
face and cytoplasm of infiltrating plasma cells, which were
positive for CD138 staining (Figure 1m–u). The mean expres-
sional scores of GRP78 of infiltrating plasma cells were 3.73
± 0.47 in synovium with follicular synovitis, 2.54 ± 0.66 in syn-
ovium with diffuse synovitis, and 1.58 ± 0.67 in those with OA.
The significant differences of GRP78 staining of infiltrating
plasma cells between RA and OA synovium and between fol-
licular and diffuse synovitis, as analyzed by the Mann-Whitney
U test, are shown in the bar graph in Figure 1.
The expression of GRP78 of plasma cells in rheumatoid 
arthritis synovial fluid
Flow cytometry analyses showed that the mean fluorescent
intensities of GRP78 of CD138+ plasma cells of synovial fluid
were 141.2 ± 43.6 in RA and 93.1 ± 24.4 in OA. The mean
fluorescent intensities of GRP78 of CD138+ plasma cells
were 169.8 ± 46.8 in follicular synovitis and 117.1 ± 21.0 in
diffuse synovitis. Figure 2 shows that there were significant dif-
ferences in mean fluorescent intensity of GRP78 of CD138+
plasma cells of synovial fluid between RA and OA as well as
between follicular and diffuse synovitis.
Western blotting analyses showed that the mean normalized
relative levels of expression of GRP78 of CD138+ plasma
cells from synovial fluid were 0.61 ± 0.14 in RA and 0.45 ±
0.10 in OA. The mean relative levels of expression of GRP78
of CD138+ plasma cells were 0.73 ± 0.07 in follicular synovitis
and 0.51 ± 0.08 in diffuse synovitis. Figure 3 shows that there
was a significant upregulation of GRP78 of synovial plasma
cells of RA relative to that of OA and an upregulation of
GRP78 of synovial plasma cells of follicular synovitis relative to
that of diffuse synovitis.
Relationship between the expression of GRP78 of 
plasma cells in synovial fluid and the corrected synovial 
fluid levels of anti-CCP in inflamed rheumatoid arthritis 
peripheral joints
The mean synovial fluid levels of anti-CCP (IgG) and IgG were
113.1 ± 53.9 RU/mL and 709.8 ± 304.8 mg/dL, respectively,
in all of the RA patients. The mean corrected synovial fluid level
of anti-CCP (IgG) was 0.17 ± 0.08 × 105 RU/g per L. The
Spearman's rho analysis showed that there was a highly posi-
tive association between the expressions of GRP78 of plasma
cells from synovial fluid and the corrected synovial fluid levels
of anti-CCP (IgG) in inflamed RA peripheral joints (Figure 4).
Discussion
The present work showed that there was an apparently
increased expression of GRP78 in infiltrating plasma cells of
RA synovium compared with that of OA synovium and that
there was a statistically significant difference between the
mean expressional levels of GRP78 in CD138+ plasma cells
from synovial fluids of RA and those of OA. These data sug-Available online http://arthritis-research.com/content/11/1/R4
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gest that enhanced activation of the UPR in infiltrating plasma
cells occurs in the autoimmune microenvironment of rheuma-
toid synovitis. Previous observations had demonstrated a
lower level of immunoglobulin synthesis of infiltrating plasma
cells in OA synovium when compared with those in RA syn-
ovium [23,24]. In addition, the highly positive association
between the expressions of GRP78 of synovial plasma cells
and the corrected synovial fluid levels of anti-CCP (IgG),
which could be related to the local antigen-driven secondary
antibody responses in rheumatoid synovium [2,4,25], was
Figure 1
Histopathological patterns and 78-kDa glucose-regulated protein (GRP78) staining of rheumatoid synovium Histopathological patterns and 78-kDa glucose-regulated protein (GRP78) staining of rheumatoid synovium. The typical synovium with dif-
fuse synovitis is shown in (a). Synovium presented diffuse lymphocyte infiltration without specific microanatomical organization. The representative 
rheumatoid synovium with follicular synovitis is shown in (b). The lymphoid aggregates are extensive and assume the appearance of discrete lym-
phoid follicles with germinal center formation. The reactive germinal center, characterized by pale-staining centroblasts with deeply stained mantle 
zones, is shown in (c). Representative immunohistochemical stainings for the sequential sections of follicular synovitis (d-f), diffuse synovitis (g-i), 
and osteoarthritis (OA) synovium (j-l) are presented. Frames (d), (g), and (j) show hematoxylin and eosin stainings. In follicular synovitis, GRP78 
stainings for plasma cells surrounding lymphoid follicles are clear and intensive in contrast to no or only weak stainings for small lymphocytes and 
large centroblasts within lymphoid follicles (e) and moderate GRP78 stainings for infiltrating plasma cells in diffuse synovitis (h). There are no or only 
weak GRP78 stainings for plasma cells (arrows) in OA synovium (k). The normal goat serum IgG replaces the primary antibody as a negative control 
(f, i, and l). Representative double-immunofluorescent stainings in synovium from rheumatoid arthritis (RA) and OA patients are shown in (m-u). 
Frames (m), (p), and (s) show the expression of CD138 (bright red fluorescent light), and frames (n), (q), and (t) show the expression of GRP78 
(bright green fluorescent light) in synovium with follicular synovitis, diffuse synovitis, and OA, respectively. Frames (o), (r), and (u) (merged) reveal the 
coexpression of CD138 and GRP78. The bar graph shows that there is a statistical difference in the expression of GRP78 of infiltrating plasma cells 
between RA (follicular synovitis + diffuse synovitis) and OA synovium (**P < 0.001) as well as between follicular and diffuse synovitis (*P < 0.001). 
Original magnifications: ×400 (a-c), ×1,000 (d-l), and ×800 (m-u). DS, diffuse synovitis; FS, follicular synovitis.Arthritis Research & Therapy    Vol 11 No 1    Dong et al.
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seen in the present study. Collectively, these findings can sug-
gest that the upregulated expression of GRP78 of plasma
cells may be at least partially related to the local production of
immunoglobulin in rheumatoid synovium.
In this study, 11 of 24 synovia sampled from the RA patients
assumed the appearance of follicular synovitis, and this ratio of
rheumatoid synovitis was apparently higher than ratios that
were previously described (approximately 30%) [6,26]. Our
data are similar to those presented in a recent report [27] and
may result in part from the fact that rheumatoid synovium with
follicular synovitis appears to be seen more frequently at sur-
geries and the fact that the presence of lymphoid follicles in
rheumatoid synovium may imply a greater risk for joint destruc-
tion [1,26]. In addition, the increased expression of GRP78 of
plasma cells in synovium and synovial fluid of follicular synovi-
tis compared with that of diffuse synovitis was seen in this
study. It can be inferred from the previous reports that the
immune microenvironment of follicular synovitis can be linked
to the combination of lymphoid microstructures and local
releases of proinflammatory cytokines, including tumor necro-
sis factor-α, interferon-γ, and interleukin-6 and interleukin-1β
[6,28,29], and the upregulated production of APRIL (a prolif-
eration-inducing ligand) capable of sustaining B-cell develop-
ment and plasmablast survival [30,31], by infiltrating myeloid
dendritic cells in rheumatoid synovium [32]. These locally pro-
duced cytokines might facilitate the cognate interactions
between follicular dendritic cells, autoreactive T cells, and B
cells within the lymphoid follicles and could stimulate the ter-
minal differentiation of B cells into long-lived and high-affinity
Figure 2
Flow cytometry analysis of the expression of 78-kDa glucose-regulated protein (GRP78) in plasma cells of synovial fluid Flow cytometry analysis of the expression of 78-kDa glucose-regulated protein (GRP78) in plasma cells of synovial fluid. The representative 
expressions of GRP78 in CD138+ plasma cells of synovial fluid of follicular synovitis, diffuse synovitis, and osteoarthritis (OA) are shown in (a-c), 
respectively. The significantly increased mean fluorescent intensity of GRP78 in CD138+ plasma cells of rheumatoid arthritis (RA) relative to OA (P 
= 0.001) and the upregulated mean fluorescent intensity of GRP78 in CD138+ plasma cells of follicular synovitis relative to that of diffuse synovitis 
(P = 0.002) are shown in (d) and (e), respectively. DS, diffuse synovitis; FITC, fluorescein isothiocyanate; FS, follicular synovitis; MFI, mean fluores-
cent intensity; PE, phycoerythrin.Available online http://arthritis-research.com/content/11/1/R4
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Figure 3
Western blotting analysis of 78-kDa glucose-regulated protein (GRP78) in isolated plasma cells from synovial fluids Western blotting analysis of 78-kDa glucose-regulated protein (GRP78) in isolated plasma cells from synovial fluids. The representative 
expressions of GRP78 in plasma cells of follicular synovitis, diffuse synovitis, and osteoarthritis (OA) are shown in (a). The representative conjugate 
control for detection of GRP78 in plasma cells of follicular synovitis is also shown in (a). The upregulated GRP78 in plasma cells of rheumatoid 
arthritis (RA) relative to that of OA (P = 0.002) and the increased expression of GRP78 in plasma cells of follicular synovitis relative to that of diffuse 
synovitis (P < 0.001) are shown in (b) and (c), respectively. DS, diffuse synovitis; FS, follicular synovitis.
Figure 4
Relationship between expressions of 78-kDa glucose-regulated protein (GRP78) of synovial plasma cells and corrected synovial fluid level of anti- cyclic citrullinated peptide antibodies (anti-CCP) (IgG) in rheumatoid arthritis Relationship between expressions of 78-kDa glucose-regulated protein (GRP78) of synovial plasma cells and corrected synovial fluid level 
of anti-cyclic citrullinated peptide antibodies (anti-CCP) (IgG) in rheumatoid arthritis. The highly positive associations of the expression of 
GRP78 of plasma cells detected by flow cytometry and Western blotting with the corrected synovial fluid level of anti-CCP (× 105 RU/g per L) are 
presented in (a) (Rs = 0.676, P < 0.001) and (b) (Rs = 0.694, P < 0.001), respectively. MFI, mean fluorescent intensity.Arthritis Research & Therapy    Vol 11 No 1    Dong et al.
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antibody-secreting plasma cells [33-35] and thus may
enhance activation of the UPR of infiltrating plasma cells in
synovium with follicular synovitis.
At present, the role of ectopic lymphoid neogenesis in rheuma-
toid synovium may be unsettled. Some reports have shown
potential links between the lymphoid neogenesis and the local
production of autoantibodies [5-7], especially anti-CCP (IgG)
[36]. But the clinical and biological relevance of synovial lym-
phoid neogenesis has been questioned recently [37,38]. With
respect to the present work, the differential expression of
GRP78 of plasma cells in distinct variants of rheumatoid syn-
ovitis, and the positive association between the expression of
GRP78 of plasma cells and the local production of anti-CCP
(IgG) within RA-inflamed peripheral joints, may provide partial
evidence for the links between ectopic lymphoid neogenesis
in rheumatoid synovium and the differentiation of autoanti-
body-secreting plasma cells as well as the ongoing local
autoimmunity [1,39,40].
Conclusion
The present work demonstrated the upregulated expression of
GRP78 of synovial plasma cells of RA compared with that of
OA, suggesting that enhanced activation of the UPR occurs in
infiltrating plasma cells within inflamed peripheral joints in RA.
In addition, there is a potential link between activation of the
UPR of infiltrating plasma cells and the ectopic lymphoid neo-
genesis as well as the local production of anti-CCP (IgG) in
rheumatoid synovium. These findings may have some implica-
tions for a better understanding of the pathogenesis of rheu-
matoid synovitis and the potential therapeutic interventions of
RA.
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